InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-10-09 | Gilbert Cisneros(D-CA31) | house | Sale | $1,001 - $15,000 |
No financial data available for AORT.
Company may not file with SEC or CIK is unresolved.
3 Reasons to Avoid AORT and 1 Stock to Buy Instead
Conestoga Capital Micro Cap Composite Q1 2026 Portfolio Holdings
Strong Catalysts Drive Artivion (AORT)
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results
Conestoga Capital Small Cap Portfolio Quarterly Scorecard: Buys, Sells, And Standouts
How The Investment Story Is Shifting For Artivion (AORT) After Recent Analyst And FDA Updates
1 Stock Under $50 to Own for Decades and 2 We Avoid
Artivion Secures FDA Approval for NEXUS Aortic Arch System
Artivion (AORT) Soars 5.3%: Is Further Upside Left in the Stock?
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know
Catalyst Watch: Nvidia's GTC Conference, FOMC meeting, Okta event, and triple-witching day
Artivion, Inc. 2025 Q4 - Results - Earnings Call Presentation